Last updated: August 15, 2023
Sponsor: The University of Hong Kong
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Lung Cancer
Neoplasms
Mild Cognitive Impairment
Treatment
Chat-type support message delivery
Regular message delivery
Clinical Study ID
NCT06003335
uhongkongc9ttii37
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- aged ≥ 18 years;
- diagnosed with stage I-III non-metastatic NSCLC cancer;
- completed primary treatment with curative intent (surgery, chemotherapy and/orradiation therapy) 6 months to 5 years prior to the baseline assessment with norecurrence or occurrence of additional cancers;
- identified as having mild cognitive impairment by the HK-MoCA 5-Min Protocol (≤ 7thage- and education-corrected percentile cut-off score);
- not engaged in regular exercise (defined as < 150 min of moderate-intensity exerciseper week).
Exclusion
Exclusion Criteria:
- inadequate reading and verbal Cantonese comprehension for the study activities;
- diagnosed with dementia;
- unable to use mobile phone text messaging applications (e.g., WhatsApp).
Study Design
Total Participants: 120
Treatment Group(s): 2
Primary Treatment: Chat-type support message delivery
Phase:
Study Start date:
March 01, 2024
Estimated Completion Date:
April 30, 2025
Connect with a study center
School of Nursing, The University of Hong Kong
Hong Kong,
Hong KongSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.